We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Get the latest from JAMA Dermatology
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Subscribe to JAMA Dermatology for the latest peer-reviewed information on a broad range of issues relating to the skin and its conditions—clinical studies, surgical therapeutics, techniques, and breakthrough treatments. Subscribe/Learn More

JAMA Dermatology Tweets

Follow us on Twitter

Connect with us on Google+

Current Highlights

Follow Us

Original Investigation | July 29, 2015 FREE ONLINE FIRST

Pembrolizumab Cutaneous Adverse Events and Disease Progression

This case series characterizes the cutaneous adverse effects of pembrolizumab in patients treated for melanoma, and associations with treatment response.

Original Investigation | July 29, 2015 FREE ONLINE FIRST

Association of Psoriatic Disease With Uveitis

This nationwide cohort study investigates associations between psoriasis or psoriatic arthritis and uveitis among Danish adults.

Original Investigation | July 22, 2015 FREE ONLINE FIRST

Cutaneous Toxic Effects of BRAF Inhibitors for Metastatic Melanoma

This cohort study compares cutaneous toxic effects of combination dabrafenib and trametinib vs vemurafenib and dabrafenib monotherapy in patients with inoperable stages IIIC and IV malignant melanoma.

Original Investigation | July 15, 2015 ONLINE FIRST

Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas

This cohort study compares long-term outcomes for patients with 1 vs multiple non-in situ cutaneous squamous cell carcinomas.

Case Report/Case Series | July 8, 2015 FREE ONLINE FIRST

Melanomas and Atypical Moles in a Patient With a Novel BAP1 Mutation

This case report describes a 53-year-old man with multiple melanomas, dysplastic nevus syndrome, and an inactivating germline BAP1 mutation.

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Interview with Maryam M. Asgari, MD, MPH, author of Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012

audio player


Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012

All Author Interviews >

Article Video

Video thumbnail

Nasal Fiberoptic Endoscopy of the Larynx and Pharynx at Day 4 in a ... (00:57)

Findings include enanthema, edema and pseudomembranes of the epiglottis, and laryngeal vestibule enanthema without involvement of the vocal cords.

All Article Videos >


Interactive preview

All Interactive >

Author Readings
Author photo

audio player


Latest Quiz

All Quizzes >

Painful Purpura on Bilateral Helices

Painful purpura on bilateral helices developed in a patient recently treated for a urinary tract infection with trimethoprim-sulfamethoxazole and levofloxacin, who was taking other multiple drugs and found to have p-ANCA positivity. What is your diagnosis?

Take this Quiz

JAMA Dermatology Patient Page

granuloma annulare

In this month's Patient Information Page, we discuss Granuloma Annulare, an uncommon skin eruption which can present locally on the backs of hands or feet, or in a more generalized pattern. While many patients spontaneously improve, recurrences are common and patients are often bothered by the appearance of the rash.

JAMA Dermatology Patient Page Collection

Past JAMA Dermatology Patient Pages are available here. Topics include bullous pemphigoid, basal cell carcinoma, morphea (localized scleroderma), squamous cell carcinoma, cutaneous lupus erythematosus, and more.

Patient Identifiability in JAMA Dermatology

morphea Robinson et al highlight the importance of quality clinical photographs, patient consent forms, and patient privacy issues in submissions to JAMA Dermatology.

Image of JAMA forum logo

Instructions for Authors

Readers who wish to submit manuscripts for consideration by JAMA Dermatology are encouraged to carefully review the criteria for manuscript composition for each of the sections in JAMA Dermatology. The editorial office will not provide specific instructions in response to e-mail inquiries by authors. Authors will be referred to the Instructions for Authors.

Physician Jobs